Authors:
GHIELMINI M
PFISTER U
ZUCCA E
VANDENBOSCH S
TAMASY P
MARANGONI G
BERTOLI G
DERIVAZ JL
CAVALLI F
Citation: M. Ghielmini et al., DISTRIBUTION OF MOBILIZED PROGENITOR CELLS IN THE BUFFY COAT OF THE HEMONETICS MCS3P CELL SEPARATOR - A STUDY TO OPTIMIZE THE COLLECTION OFPROGENITORS BY LEUKAPHERESIS, Journal of hematotherapy, 7(3), 1998, pp. 251-256
Authors:
GHIELMINI M
COLLI E
ERBA E
BERGAMASCHI D
PAMPALLONA S
JIMENO J
FAIRCLOTH G
SESSA C
Citation: M. Ghielmini et al., IN-VITRO SCHEDULE-DEPENDENCY OF MYELOTOXICITY AND CYTOTOXICITY OF ECTEINASCIDIN 743 (ET-743), Annals of oncology, 9(9), 1998, pp. 989-993
Authors:
PARCHMENT RE
GORDON M
GRIESHABER CK
SESSA C
VOLPE D
GHIELMINI M
Citation: Re. Parchment et al., PREDICTING HEMATOLOGICAL TOXICITY (MYELOSUPPRESSION) OF CYTOTOXIC DRUG-THERAPY FROM IN-VITRO TESTS, Annals of oncology, 9(4), 1998, pp. 357-364
Authors:
ZAPPA F
GHIELMINI M
CORTI R
CAVALLI F
GALLINO A
Citation: F. Zappa et al., VENTRICULAR DIASTOLIC FUNCTION CHANGES IN PATIENTS WITH LYMPHOMA UNDERGOING HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND STEM-CELL TRANSPLANTATION, Annals of oncology, 9, 1998, pp. 533-533
Authors:
GHIELMINI M
COLLI E
BOSSHARD G
ZUCCHETTI M
DINCALCI M
GERONI C
SESSA C
Citation: M. Ghielmini et al., EVALUATION OF THE HEMATOTOXIC POTENTIAL OF METHOXYMORPHOLINYL-DOXORUBICIN (MMDX) METABOLITES IN PATIENTS PLASMA BY CLONOGENIC ASSAYS ON HEMATOPOIETIC PROGENITOR CELLS, Annals of oncology, 9, 1998, pp. 206-206
Authors:
SESSA C
ZUCCHETTI M
BAUER J
NAEGELE H
DINCALCI M
GHIELMINI M
ROSSI S
VANDENBULCKE T
PACCIARINI M
DOMENIGONI L
CAVALLI F
Citation: C. Sessa et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ORAL (PO) METHOXY-MORPHOLINO DOXORUBICIN (PNU-152243) ON A SINGLE INTERMITTENT SCHEDULE, Annals of oncology, 9, 1998, pp. 450-450
Authors:
GHIELMINI M
COLLI E
ERBA E
BERGAMOSCHI D
JIMENO J
FAIRCLOTH G
SESSA C
Citation: M. Ghielmini et al., IN-VITRO CYTOTOXICITY OF ECTEINASCIDIN-743 (ET-743) AGAINST HUMAN HEMATOPOIETIC PROGENITORS AND CANCER-CELLS, Annals of oncology, 9, 1998, pp. 533-533
Authors:
GHIELMINI M
COLLI E
BOSSHARD G
PENNELLA G
GERONI C
TORRI V
DINCALCI M
CAVALLI F
SESSA C
Citation: M. Ghielmini et al., HEMATOTOXICITY ON HUMAN BONE MARROW-DERIVED AND UMBILICAL-CORD BLOOD-DERIVED PROGENITOR CELLS AND IN-VITRO THERAPEUTIC INDEX OF METHOXYMORPHOLINYLDOXORUBICIN AND ITS METABOLITES, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 235-240
Authors:
CORSINI C
MANCUSO P
GHIELMINI M
ZUCCHETTI M
TEALDO F
COCOROCCHIO E
FERRUCCI PF
PECCATORI F
DINCALCI M
MARTINELLI G
Citation: C. Corsini et al., INHIBITION OF CFU-GM GROWTH BY IDARUBICINOL CONTAINING PLASMA SAMPLESOBTAINED FROM POOR-PROGNOSIS LYMPHOMA PATIENTS TREATED WITH 3-DAYS INFUSION IDARUBICIN, Experimental hematology, 26(8), 1998, pp. 378-378
Authors:
BERETTA F
VANDENBOSCH S
CASTELLI D
CAVALLI F
GHIELMINI M
Citation: F. Beretta et al., INTRAPATIENT COMPARISON OF AN INTERMITTENT AND A CONTINOUS FLOW CELL SEPARATOR FOR THE COLLECTION OF PROGENITOR AND STEM-CELLS FROM THE BLOOD, Vox sanguinis, 75(2), 1998, pp. 149-153
Authors:
SANNA P
VANDENBOSCH S
CAVALLI F
GHIELMINI M
Citation: P. Sanna et al., HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH AUTOLOGOUS BLOOD STEM-CELL RESCUE FOR RELAPSED OR RESISTANT LYMPHOMA, Schweizerische medizinische Wochenschrift, 128(40), 1998, pp. 1500-1507
Authors:
COLLEONI M
GRAFFEO R
MARTINELLI G
GHIELMINI M
DEBRAUD P
ZAMPINO G
MARINI G
CAVALLI F
GOLDHIRSCH A
Citation: M. Colleoni et al., CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS, Oncology Reports, 4(5), 1997, pp. 913-916
Authors:
COLLEONI M
GRAFFEO R
MARTINELLI G
GHIELMINI M
MARINI G
CAVALLI F
GOLDHIRSCH A
Citation: M. Colleoni et al., CISPLATIN, ETOPOSIDE AND BLEOMYCIN INFUSION (PEBI REGIMEN) IN GOOD-RISK PATIENTS WITH GERM-CELL TUMORS, European journal of cancer, 33, 1997, pp. 176-176
Authors:
GHIELMINI M
COLLI E
JIMENO J
FAIRCLOTH G
SESSA C
Citation: M. Ghielmini et al., SCHEDULE-DEPENDENT MYELOTOXICITY INDUCED IN-VITRO BY THE NEW MARINE DERIVED MINOR-GROOVE INTERACTING AGENT ECTEINASCIDIN-743, European journal of cancer, 33, 1997, pp. 807-807
Authors:
MARTINELLI G
PECCATORI F
ULLRICH B
GHIELMINI M
ROGGERO E
GOLDHIRSCH A
Citation: G. Martinelli et al., CLINICAL MANIFESTATION OF SEVERE HYPERAMMONEMIA IN PATIENTS WITH MULTIPLE-MYELOMA, Annals of oncology, 8(8), 1997, pp. 811-811
Citation: M. Ghielmini et al., TRANSPLANTATION OF AUTOLOGOUS BLOOD STEM-CELLS AFTER HIGH-DOSE SEQUENTIAL CHEMOTHERAPY FOR LYMPHOMA REPOPULATES THE BONE-MARROW TO A MINIMAL PROPORTION OF THE ORIGINAL STEM-CELL CONTENT, Experimental hematology, 25(8), 1997, pp. 279-279
Authors:
REGAZZONI S
MARINI G
GROB A
PEDRAZZINI A
GOLDHIRSCH A
CASTELLI D
CAVALLI F
GHIELMINI M
Citation: S. Regazzoni et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IS FEASIBLE AND SAFE IN A REGIONAL-HOSPITAL - A 6-YEAR EXPERIENCE IN SOUTHERN SWITZERLAND, Bone marrow transplantation, 19(1), 1997, pp. 3-7
Authors:
GHIELMINI M
BOSSHARD G
CAPOLONGO L
GERONI MC
PESENTI E
TORRI T
DINCALCI M
CAVALLI F
SESSA C
Citation: M. Ghielmini et al., ESTIMATION OF THE HEMATOLOGICAL TOXICITY OF MINOR-GROOVE ALKYLATORS USING TESTS ON HUMAN CORD-BLOOD CELLS, British Journal of Cancer, 75(6), 1997, pp. 878-883
Authors:
SESSA C
ROGGERO E
PAMPALLONA S
REGAZZONI S
GHIELMINI M
LANG M
MARX B
NEUENSCHWANDER H
PAGANI O
VASILIEVIC V
CAVALLI F
Citation: C. Sessa et al., THE LAST 3 MONTHS OF LIFE OF CANCER-PATIENTS - MEDICAL ASPECTS AND ROLE OF HOME-CARE SERVICES IN SOUTHERN SWITZERLAND, Supportive care in cancer, 4(3), 1996, pp. 180-185
Citation: M. Ghielmini et al., BONE-MARROW PARAMETERS ASSOCIATED WITH PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH RELAPSED LYMPHOMA, Experimental hematology, 24(9), 1996, pp. 612-612
Citation: M. Ghielmini et A. Tobler, MOBILIZATION AND TRANSPLANTATION OF AUTOL OGOUS HEMATOPOIETIC STEM AND PROGENITOR CELLS FROM THE BLOOD, Schweizerische medizinische Wochenschrift, 126(9), 1996, pp. 348-356
Authors:
GHIELMINI M
PETTENGELL R
COUTINHO LH
TESTA N
CROWTHER D
Citation: M. Ghielmini et al., THE EFFECT OF THE GM-CSF IL-3 FUSION PROTEIN PIXY321 ON BONE-MARROW AND CIRCULATING HEMATOPOIETIC-CELLS OF PREVIOUSLY UNTREATED PATIENTS WITH CANCER/, British Journal of Haematology, 93(1), 1996, pp. 6-12
Citation: M. Ghielmini, 3RD INTERNATIONAL-SYMPOSIUM ON RECENT ADVANCES IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Annals of oncology, 6(6), 1995, pp. 533-536
Authors:
SCHEID C
PETTENGELL R
GHIELMINI M
RADFORD JA
MORGENSTERN GR
STERN PL
CROWTHER D
Citation: C. Scheid et al., TIME-COURSE OF THE RECOVERY OF CELLULAR IMMUNE FUNCTION AFTER HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR HIGH-GRADE NON-HODGKINS-LYMPHOMA, Bone marrow transplantation, 15(6), 1995, pp. 901-906